Center for Cancer
Immunotherapy and
Immunobiology

MessageMessage from the Director

Established in April 2020, the Kyoto University Center for Cancer Immunotherapy and Immunobiology (CCII) is devoted to advancing immunology and cancer research with the aim of transforming the society through science. The mission of CCII is to…

＞ more

Overview

The Center for Cancer Immunotherapy and Immunobiology (CCII) was established in April 2020 as an affiliated education and research facility of the Kyoto University Graduate School of Medicine in order to address various issues in cancer…

＞ more

MembersMembers and Laboratories

We provide you with the information regarding the CCII's laboratories and members, including Prof. Honjo.
This page will be updated as new members join the CCII.

＞ more

Appearance of the Bristol Myers Squibb Buidling at the Center for Cancer Immunotherapy and Immunobiology
Drawn by Mr. Tadao Ando (as of February 2021)→Details

New CCII Building

Cancer Immunotherapy Research Fund

Cancer therapy has continually advanced, allowing many cancer patients to return to years of a normal…　
　

＞ more

News

2022.03.10
“From cell death to cancer immunotherapy”: The EMBO Podcast with Professor Honjo
2022.03.10
“Immunology as the Ultimate System Biology", Paper published in Nature by Prof. Fagarasan and her collaborators
2022.01.19
Donald Brown - 90th Birthday Celebration & Symposium (January 26 at 5:00 PM EDT // Live via Zoom)
2021.12.10
Ambassador of Germany in Japan visits Kyoto University (December 6, 2021)
2021.11.19
[CLOSED]Call for Applications: Professor Position in the Division of Cancer Immune Regulation
2021.10.18
The 8th Kyoto University-Inamori Foundation Joint Kyoto Prize Symposium (to be held from 13:00 on February 13, 2022)(JST)
2021.09.10
[CLOSED]Call for Applications: Associate Professor Position in the Division of Cancer Immunotherapy (Deadline: 17:00 on November 9, 2021)(JST)
2021.09.10
[CLOSED]Call for Applications: Tenure-Track Associate Professor Position in the Multiomics Platform (Deadline: 17:00 on September 30, 2021)(JST)
2021.07.19
Brief report of the 6th CCII Seminar
2021.06.07
[Research Results] Rejuvenation of aged immune cells improves PD-1 blockade cancer immunotherapy
2021.06.03
Brief report of the 5th CCII Seminar
2021.05.28
Dr. Tasuku Honjo receives a UBC honorary degree
2021.04.13
KU-UCSD/CNT Seminar #7: Event Announcement
2021.03.12
Cancer Immunotherapy Research Fund (Kyoto University Fund) established
2021.02.10
Brief report of the 1st International Symposium of CCII -Bioinformatics and its application to cancer and other diseases-
2021.01.29
[CLOSED]Call for Applications: Tenure-Track Program-Specific Associate Professor Position in the Metabolome Platform (Deadline: 17:00 on February 18, 2021)(JST)
2021.01.26
Construction of the Bristol Myers Squibb Building at the Center for Cancer Immunotherapy and Immunobiology